Next report date
Report period
Q1 2024
EPS estimate
−0.63USD
Revenue estimate
6.91 MUSD
−98.43 MUSD
34.16 MUSD
18.71 M
Om Foghorn Therapeutics Inc.
Sektor
Bransch
VD
Adrian Gottschalk
Webbplats
Huvudkvarter
Cambridge
Employees (FY)
116
Grundat
2015
FIGI
BBG00HFZPB88
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
